OSR Holdings (OSRH) Fundamentals 2026 — Revenue Analysis | SniperIQ
OSR Holdings (OSRH) is a US-listed Healthcare company in Biotechnology with a market capitalization of
M in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is OSR Holdings's market cap?
OSR Holdings (OSRH) has a market capitalization of approximately
What is OSR Holdings's P/E ratio?
OSR Holdings's trailing twelve-month P/E ratio is not meaningful (negative or nil earnings), with a price-to-book (P/B) of 0.0x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is OSR Holdings?
OSR Holdings runs a net profit margin of -525.1%, a gross margin of -70.0%, and an operating margin of -726.1%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does OSR Holdings generate?
OSR Holdings reported revenue of
Does OSR Holdings pay a dividend?
OSR Holdings does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.
Is OSR Holdings financially healthy?
OSR Holdings carries a debt-to-equity ratio of 0.05x and a current ratio of 0.16x, with a market beta of 0.72. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is OSR Holdings a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For OSR Holdings (OSRH) the key facts are: market cap
M, 52-week range 0.3-1.24. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.Track OSR Holdings's full fundamentals live
Get OSR Holdings's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.